Posted on 09/09/2022 11:02:22 AM PDT by Red Badger
Date Issued: September 8, 2022
The U.S. Food and Drug Administration (FDA) is informing the public about reports of cancers, including squamous cell carcinoma (SCC) and various lymphomas, in the scar tissue (capsule) that forms around breast implants. The various lymphomas reported are not the same as the lymphomas described in previous FDA Communications as Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). The FDA learned about these reports through our continual postmarket review of breast implants and our ongoing collaboration with external stakeholders.
After preliminary review of published literature as part of our ongoing monitoring of the safety of breast implants, the FDA is aware of less than 20 cases of SCC and less than 30 cases of various lymphomas in the capsule around the breast implant. As of September 1, 2022, the FDA has received 10 medical device reports (MDRs) about SCC related to breast implants and 12 MDRs about various lymphomas related to breast implants. The FDA recognizes the limitations of MDR data, including that reports do not necessarily represent unique cases. Reports submitted to the FDA are just one source the FDA uses to monitor the safety of medical devices, in addition to mandated postmarket studies, published literature, and real-world data from registries and claims databases. The FDA will continue to gather and review all available data from these sources to evaluate the occurrence of cancers in the capsule around breast implants.
While the FDA believes that occurrences of SCC or various lymphomas in the capsule around the breast implant may be rare, health care providers and people who have or are considering breast implants should be aware that cases have been reported to the FDA and in the literature. Currently, the incidence rate and risk factors for SCC and various lymphomas in the capsule around the breast implants are unknown. When breast implant information was provided, there have been literature reports of SCC and various lymphomas in the capsule around the breast implants for both textured and smooth breast implants, and for both saline and silicone breast implants. In some cases, people were diagnosed after years of having breast implants. Some of the reported signs and symptoms included swelling, pain, lumps or skin changes.
This is an emerging issue and our understanding is evolving. For this reason, the FDA is asking health care providers and people with breast implants to report cases of SCC, lymphomas, or any other cancers around the breast implant to the FDA.
Recommendations for People who Have or Are Considering Breast Implants:
If you are considering breast implants or if you have them, learn more about the risks and benefits of breast implants.
If you have breast implants, you do not need to change your routine medical care or follow-up.
Be aware that cases of SCC and various lymphomas in the capsule around the breast implant have been reported.
Monitor your breast implants for as long as you have them. If you notice any abnormal changes in your breasts or implants, promptly talk to your surgeon or health care provider.
If you do not have symptoms, the FDA does not recommend the removal of breast implants because of this safety communication.
If you have breast implants and experience a problem, the FDA encourages you to file a report through MedWatch, the FDA Safety Information and Adverse Event Reporting program. Your report, along with information from other sources, can provide information that helps improve patient safety.
Currently, these recommendations do not change or affect the recommendations previously provided by the FDA on BIA-ALCL.
Recommendations for Health Care Providers:
Continue to provide routine care and support to your patients with breast implants.
Be aware that cases of SCC and various lymphomas in the capsule around the breast implant have been reported.
When examining breast implant specimens (for example, seroma, capsule, devices) for diagnostic evaluation, characterize all findings and potential diagnoses.
Report cases of SCC, lymphomas, and any other cancers in the capsule around the breast implant to the FDA.
Prompt reporting of adverse events can help the FDA identify and better understand the risks associated with medical devices.
Currently, these recommendations do not change or affect the recommendations previously provided by FDA on BIA-ALCL.
Device Description
Breast implants are medical devices implanted under the breast tissue or chest muscle to increase breast size (augmentation) or to replace breast tissue that has been removed due to cancer or trauma or that has failed to develop properly due to a severe breast abnormality (reconstruction). They are also used in revision surgeries, which seek to correct or improve the result of an original surgery.
There are two types of breast implants approved for sale in the United States: saline-filled and silicone gel-filled. Both types have a silicone outer shell. They vary in size, shell thickness, shell surface texture, and shape (contour). Breast implants are not lifetime devices. The longer you have your implants, the more likely it will be for you to have them removed or replaced.
FDA Actions
The FDA is continually evaluating the postmarket safety of approved breast implants and communicating about the risks associated with these devices. Since 2011, the FDA has been collecting and evaluating information about BIA-ALCL. The FDA will collaborate with other regulatory authorities, clinical and scientific experts, manufacturers, and breast implant registries, to gather all available information about SCC, lymphomas, and any other cancers in the capsule around the breast implant. We will continue to communicate to the public on significant findings as new information and analyses become available.
Reporting Problems with Your Device
If you think you had a problem with your device, the FDA encourages you to report the problem through the MedWatch Voluntary Reporting Form.
Health care personnel employed by facilities that are subject to the FDA's user facility reporting requirements should follow the reporting procedures established by their facilities.
Questions?
If you have questions, email the Division of Industry and Consumer Education (DICE) at DICE@FDA.HHS.GOV or call 800-638-2041 or 301-796-7100.
I tried to talk two women out of having implants. Failed with both. They looked better before being "enhanced," but it's not a subject I raise.
I’ve never felt another woman’s breasts, real or fake (!) but I can’t imagine they feel natural either - whether ‘wearing’ them or touching them...
My SIL had a boob job every time I give her a hug in greeting or leaving her chest is as hard as a rock!! Just YUCK!!!
Is this showing up now because of the vaccine messing with immune systems??
Danica Patrick, the former race car driver, claims she’s much healthier after having hers removed.
I wonder if those women would have developed the findings had they not had the implants?
I wonder if those women would have developed the findings had they not had the implants?
That was covered in the 1991 Steve Martin film "LA Story." The joke is that so many women in LA have implants that Steve Martin thinks that Sarah Jessica Parker's natural breasts feel strange:
https://getyarn.io/yarn-clip/2fada5a7-8d5b-417b-a7f0-d94c706bf746
No, this has been suspected for decades...................
Because men.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.